Understanding the Texas Hemp Ban and Its Impact on Patients
The texas hemp ban significantly affects patients relying on smokable THC products. Clinicians must counsel patients on alternative delivery methods due to new regulations. Understanding the texas hemp ban helps maintain effective patient care.
New Study Links Cannabis Vaping to Cannabinoid Hyperemesis Syndrome
Cannabinoid hyperemesis syndrome vaping risks are increasingly recognized in clinical settings. This condition causes severe vomiting linked to cannabis vaping. Understanding these risks helps clinicians diagnose and manage patients effectively.
Pain Meds and Cannabis Edibles: Leading Causes of Pediatric Poisonings in Wisconsin
Accidental cannabis edible poisoning children is an emerging pediatric health concern in Wisconsin. Edible cannabis products often resemble candy, increasing poisoning risks. Clinicians must counsel families on safe storage to prevent accidental…
Medical Cannabis Bill Adds Vaping, Insomnia for Georgia Patients – State Affairs Pro
The medical cannabis vaping insomnia bill in Georgia allows clinicians to recommend vaping for patients with severe insomnia. This expands treatment options beyond smoking and may improve adherence and lung health. Clinicians should understand vaping…
What Is THCA in Cannabis Flower? Biosynthesis, Stability, and Potency Calculations
THCA stability and biosynthesis are crucial for understanding cannabis flower potency. THCA converts to psychoactive THC through heating, affecting dosing and effects. Clinicians must grasp these concepts for accurate patient guidance.
Daily Digest: Last 24 Hours: Cannabinoids and Liver Disease Lead a Research-Heavy Cycle — March 08, 2026
This digest highlights the latest research on cbd and cbg for fatty liver disease, emphasizing key clinical implications. Advances in cannabinoid drug delivery science also feature prominently. Regulatory updates across North America further shape the…
Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and … – PubMed
Cannabinoid oral mucosal delivery offers a promising approach to improve bioavailability and dosing consistency. This method bypasses hepatic first-pass metabolism, enhancing therapeutic efficacy. Research on oral mucosal delivery systems addresses…